Literature DB >> 2473969

Beta-cluster haplotypes, alpha-gene status, and hematological data from SS, SC, and S-beta-thalassemia patients in southern California.

W A Schroeder1, D R Powars, L M Kay, L S Chan, V Huynh, J B Shelton, J R Shelton.   

Abstract

The beta-gene-cluster haplotype and alpha-gene status were determined for 221 patients with sickle cell anemia, 41 with SC disease, and 21 with S-beta-thalassemia. Among SS patients, eleven beta S haplotypes were found in 21 combinations. Three haplotypes--the Benin (Ben) [---+-], the Central African Republic (CAR) [+---+], and the Senegal (Sen) [+- ]--comprise 61%, 21%, and 10% of the chromosomes, respectively. Cleavage at the Xmn I site 5' to the G gamma gene was observed only when the Senegalese arrangement was present. The linear correlation which exists between the absolute value of the G gamma chains and the Hb F for each haplotype combination suggests a feed-back mechanism which controls the G gamma to A gamma ratio and thus the Hb F level (or vice versa). The A gamma T chain was present with specific haplotypes [++-++] and [++-+-]. Heterozygous or homozygous alpha-thalassemia-2 was present in 36% of the SS patients and was randomly distributed among beta S-gene-cluster haplotypes. The variable levels of hemoglobin, MCV, Hb F, G gamma chains, and Hb A2 are in response to the heterogeneous genetic mix of the beta S-gene-cluster haplotypes and alpha-thalassemia-2 in American patients with sickle cell anemia. The influence of alpha-thalassemia-2 on the level of Hb F is dependent on the beta S-cluster haplotype. Hb A2 levels increased with decrease in the number of alpha genes. Among SC and S-beta-thalassemia patients the beta-cluster polymorphisms on the beta S chromosome were those commonly associated with the African origins of beta S haplotype. The haplotype [+--+-] was present on the C chromosome in 90% of the cases. Most beta-thalassemia chromosomes had haplotypes that matched the common African polymorphisms. An alpha-gene deletion was found in 29% of the SC and S-beta-thalassemia patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473969     DOI: 10.3109/03630268909003397

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  10 in total

1.  Nucleotide sequence evidence of the unicentric origin of the beta C mutation in Africa.

Authors:  G Trabuchet; J Elion; O Dunda; C Lapouméroulie; R Ducrocq; S Nadifi; I Zohoun; A Chaventre; P Carnevale; R L Nagel
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132

2.  Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.

Authors:  Nadia Solovieff; Jacqueline N Milton; Stephen W Hartley; Richard Sherva; Paola Sebastiani; Daniel A Dworkis; Elizabeth S Klings; Lindsay A Farrer; Melanie E Garrett; Allison Ashley-Koch; Marilyn J Telen; Supan Fucharoen; Shau Yin Ha; Chi-Kong Li; David H K Chui; Clinton T Baldwin; Martin H Steinberg
Journal:  Blood       Date:  2009-12-16       Impact factor: 22.113

Review 3.  Sickle cell vasoocclusion: many issues and some answers.

Authors:  D K Kaul; R L Nagel
Journal:  Experientia       Date:  1993-01-15

4.  Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia.

Authors:  Christopher J Bean; Sheree L Boulet; Genyan Yang; Amanda B Payne; Nafisa Ghaji; Meredith E Pyle; W Craig Hooper; Pallav Bhatnagar; Jeffrey Keefer; Emily A Barron-Casella; James F Casella; Michael R Debaun
Journal:  Br J Haematol       Date:  2013-08-16       Impact factor: 6.998

5.  Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea.

Authors:  Françoise Bernaudin; Cécile Arnaud; Annie Kamdem; Isabelle Hau; Françoise Lelong; Ralph Epaud; Corinne Pondarré; Serge Pissard
Journal:  Blood Adv       Date:  2018-03-27

6.  Self-catalytic DNA depurination underlies human β-globin gene mutations at codon 6 that cause anemias and thalassemias.

Authors:  Juan R Alvarez-Dominguez; Olga Amosova; Jacques R Fresco
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

7.  Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease.

Authors:  Carly C Ginter Summarell; Vivien A Sheehan
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-17

8.  Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease.

Authors:  James G Taylor; Diana Ackah; Crystal Cobb; Nick Orr; Melanie J Percy; Vandana Sachdev; Roberto Machado; Oswaldo Castro; Gregory J Kato; Stephen J Chanock; Mark T Gladwin
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

9.  Modulating Effect of the -158 γ (C→T) Xmn1 Polymorphism in Indian Sickle Cell Patients.

Authors:  Sanjay Pandey; Sweta Pandey; Rahasya Mani Mishra; Renu Saxena
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-01-15       Impact factor: 2.576

10.  Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen.

Authors:  Gaye T Adams; Harold Snieder; Virgil C McKie; Betsy Clair; Donald Brambilla; Robert J Adams; Ferdane Kutlar; Abdullah Kutlar
Journal:  BMC Med Genet       Date:  2003-07-18       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.